Prime Global and Raremark Partner for Patients with Rare Diseases


Prime Global and Raremark have announced a partnership aiming to transform solutions for patients with rare diseases.

The partnership will combine Raremark’s Xperiome platform for patients with Prime Global’s 23 years of medical communications experience aiming to uncover insights into the entire patient journey that will allow the creation of a patient-centric drug development and commercialization programs.

For more information, click here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.